Procter & Gamble Jumps 6% as Earnings Beat Draws Defensive Buyers; Johnson & Johnson Rises 3%, Coca-Cola Ticks Up

Defensive consumer and healthcare stocks are drawing fresh money. As large-caps generally fall, Procter & Gamble‘s (NYSE:PG | PG Price Prediction) quarterly beat is catching the interest of today's buyers.

22.10.2026

JNJ Stock Has a New Growth Story, but One Business Needs to Catch Up

Johnson and Johnson just posted a quarter where one business charged ahead while another quietly stalled, and which side wins out will determine whether the stock earns its premium valuation over rivals like Merck and AbbVie.

22.10.2026

Social Security Isn't Enough: 5 Secure Dividend Stocks to Fund Your Retirement

A 3.3% Social Security bump leaves most retirees short, but five blue-chip dividend payers across four sectors have quietly built the kind of growing income stream that picks up where the government leaves off.

22.10.2026

Johnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026

IRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson reports first real-world VARIPULSE Pro Platform data and 12-Month OMNYPULSE Platform outcomes for atrial fibrillation treatment.

21.10.2026

Johnson & Johnson Raised Its Dividend Every Year. Why Did It Trail the S&P 500?

Johnson and Johnson has raised its dividend every single year for 64 years straight, yet a plain S&P 500 index fund still beat it handily over the past decade.

21.10.2026

3 of the Best Value Stocks to Own

#StockstoBuy #ValueStocks #TheMorningFilter These value stocks with wide economic moats are good long-term investments when you can buy them at a discount.

21.10.2026

Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?

Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Видео

21.10.2026

Positive

3 of the Best Value Stocks to Own

14.10.2026

Negative

Johnson & Johnson shares SLIDE nearly 6% despite stronger full-year forecast

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
JNJ	Erste Group	Hold	undefined >> undefined	October 21st 2026
JNJ	UBS	Buy	undefined >> $320	September 2nd 2026

Пресс-релизы

22.10.2026

Johnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026

IRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson reports first real-world VARIPULSE Pro Platform data and 12-Month OMNYPULSE Platform outcomes for atrial fibrillation treatment.

Johnson & Johnson (JNJ)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Контакты

Мы в соцсетях

Johnson & Johnson (JNJ)

Procter & Gamble Jumps 6% as Earnings Beat Draws Defensive Buyers; Johnson & Johnson Rises 3%, Coca-Cola Ticks Up

JNJ Stock Has a New Growth Story, but One Business Needs to Catch Up

Social Security Isn't Enough: 5 Secure Dividend Stocks to Fund Your Retirement

Johnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026